Accurium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accurium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accurium Today - Breaking & Trending Today

Curium Announces Ioflupane I 123 Injection Availability for

Exciting news from Curium! Starting April 5, 2024, our Ioflupane I 123 Injection will be delivered Monday through Friday.. ....

United States , Robert Burke , Pierre Curie , Ross Bethell , Florida Brain Bank Alzheimer Disease , Quarterly Journal Of Nuclear Med Mol Imaging , North American Senior Vice President , Prescribing Information , North America , Florida Brain Bank , Associated Disorders , Nuclear Med Mol Imaging , Curium Us Llc , Oflupanei 123 , Parkinsonian Syndrome , Brain Imaging , Lewy Bodies , Uclear Medi ,

Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer

PARIS, Nov. 16, 2023 (GLOBE NEWSWIRE) Curium, a world leader in nuclear medicine, announced today that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the first patients in Greece have been injected with PYLCLARI® (INN: Piflufolastat (18F) also known as (18 F)-DCFPyL, indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in patients with prostate cancer in the following clinical se ....

United States , France General , Benoit Woessmer , Pierre Curie , Ross Bethell , Savvas Thalasselis , European Union , Head Of Global Communications , Cath Lab , European Commission , Managing Director , Prostate Cancer , Nuclear Medicine , Positron Emission Tomography , Curative Therapy , Savvas Thalasselis ,

Accurium expands its education offering to accountants

SMSF education specialist Accurium is expanding its services to provide a comprehensive professional development offering for accountants. Doug McBirnie, managing director of Accurium, said more ....

Lee Ann Hayes , Anthony Cullen , Mark Ellem , Eann Hayes ,

EU Approves Piflufolastat (18F) PSMA PET Imaging Agent for Prostate Cancer

The European Commission has approved piflufolastat (18F) for the detection of prostate-specific membrane antigen–positive lesions with positron emission tomography in adults with prostate cancer. ....

Sakir Mutevelic , European Commission , European Union , Lantheus Holdings Inc , European Medicines Agency , Medicinal Products , Human Use , Piflufolastat 18f , Adults With Prostate Cancer , Osprey Trial , Condor Trial ,

Curium Receives Positive CHMP Opinion of PYLCLARI® for

If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as [18F]-DCFPyL) will offer prostate cancer patients access to a diagnostic. ....

France General , United States , Pierre Curie , Sakir Mutevelic , Ross Bethell , Benoit Woessmer , Committee For Medicinal Products Human Use , Head Of Global Communications , European Commission , Drug Administration , European Medicines Agency , Medicinal Products , Human Use , Chief Medical Officer , Marketing Authorization Application , Curium Us Llc , Clinical Trials , Prostate Cancer , Get Scan ,